✦ LIBER ✦

Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: A single-center experience

✍ Scribed by Holbrook E. Kohrt; Samit Patel; Michelle Ho; Terri Owen; Daniel A. Pollyea; Ravindra Majeti; Jason Gotlib; Steve Coutre; Michaela Liedtke; Caroline Berube; Ash A. Alizadeh; Bruno C. Medeiros

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 117 KB
Volume: 85
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21857

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FLAIE (fludarabine, cytarabine, idarubic

FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience

✍ Anna Candoni; Erica Simeone; Mario Tiribelli; Michele Malagola; Domenico Russo; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

Gemtuzumab ozogamicin with cytarabine an

Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience

✍ G. Specchia; D. Pastore; P. Carluccio; G. Spinosa; M. Giannoccaro; R. Rizzi; A. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 95 KB

Single-dose mitoxantrone in combination

Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia

✍ Sung-Sook Lee; Je-Hwan Lee; Jung-Hee Lee; Dae-Young Kim; Se Hyung Kim; Sung-nam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Mitoxantrone, etoposide, and cytarabine

Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia : An Eastern Cooperative Oncology Group pilot study

✍ Martin S. Tallman; Sandra Lee; Branimir I. Sikic; Elisabeth Paietta; Peter H. Wi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Background: One potential mechanism of drug resistance to chemotherapy is the overexpression of multidrug resistance (mdr) genes coding for p-glycoprotein (p-gp), which leads to reduced intracellular retention of chemotherapy. this study tested the efficacy and toxicity of mitoxantrone, etoposid

Minimally differentiated acute myeloid l

Minimally differentiated acute myeloid leukemia (AML-M0) in children: A single center experience

✍ Kuzmanovic, Milos; Rasovic, Nada; Bunjevacki, Gordana; Scekic-Guc, Marija; Bunje 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 1 views

Pharmacology of cytarabine given as a co

Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia

✍ Fevzi Ozkaynak, M.; Avramis, Vassilios I.; Carcich, Sherri; Ortega, Jorge A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 3 views

Background. The outcome of patients with acute myeloid leukemia (AML) who relapse or fail to achieve an initial remission has been dismal. Procedure. Fifteen pediatric patients with AML, 4 relapsed and 11 primary refractory, were reinduced with a loading bolus of 0.5 g/m 2 cytarabine (ara-C) followe